| Sylvant |
Human |
siltuximab |
siltuximab |
EMEA/H/C/003708 |
Recordati Netherlands B.V. |
2014/05/22
|
Authorised |
| Jardiance |
Human |
empagliflozin |
empagliflozin |
EMEA/H/C/002677 |
Boehringer Ingelheim International GmbH |
2014/05/22
|
Authorised |
| Entyvio |
Human |
vedolizumab |
vedolizumab |
EMEA/H/C/002782 |
Takeda Pharma A/S |
2014/05/22
|
Authorised |
| Ebilfumin |
Human |
oseltamivir |
oseltamivir |
EMEA/H/C/003717 |
Actavis Group PTC ehf |
2014/05/22
|
Authorised |
| Olysio |
Human |
simeprevir |
simeprevir |
EMEA/H/C/002777 |
Janssen-Cilag International NV |
2014/05/14
|
Withdrawn |
| Laventair Ellipta (previously Laventair) |
Human |
umeclidinium bromide;vilanterol |
umeclidinium bromide;vilanterol |
EMEA/H/C/003754 |
GlaxoSmithKline Trading Services Limited |
2014/05/08
|
Authorised |
| Anoro Ellipta (previously Anoro) |
Human |
umeclidinium bromide;vilanterol |
umeclidinium bromide;vilanterol trifenatate |
EMEA/H/C/002751 |
GlaxoSmithKline Trading Services Limited |
2014/05/08
|
Authorised |
| Revinty Ellipta |
Human |
fluticasone furoate;vilanterol |
fluticasone furoate;vilanterol trifenatate |
EMEA/H/C/002745 |
GlaxoSmithKline Trading Services Limited |
2014/05/02
|
Authorised |
| Incruse Ellipta (previously Incruse) |
Human |
umeclidinium bromide |
umeclidinium bromide |
EMEA/H/C/002809 |
GlaxoSmithKline Trading Services Limited |
2014/04/28
|
Authorised |
| DuoResp Spiromax |
Human |
budesonide;formoterol |
Budesonide;formoterol fumarate dihydrate |
EMEA/H/C/002348 |
Teva Pharma B.V. |
2014/04/28
|
Authorised |
| BiResp Spiromax |
Human |
budesonide;formoterol |
Budesonide;formoterol fumarate dihydrate |
EMEA/H/C/003890 |
Teva Pharma B.V. |
2014/04/28
|
Authorised |
| Deltyba |
Human |
delamanid |
Delamanid |
EMEA/H/C/002552 |
Otsuka Novel Products GmbH |
2014/04/27
|
Authorised |
| Vimizim |
Human |
elosulfase alfa |
recombinant human n-acetylgalactosamine-6-sulfatase |
EMEA/H/C/002779 |
BioMarin International Limited |
2014/04/27
|
Authorised |
| Ulunar Breezhaler |
Human |
indacaterol;glycopyrronium bromide |
glycopyrronium bromide;indacaterol maleate |
EMEA/H/C/003875 |
Novartis Europharm Limited |
2014/04/23
|
Authorised |
| Vokanamet |
Human |
canagliflozin;metformin |
canagliflozin;metformin hydrochloride |
EMEA/H/C/002656 |
Janssen-Cilag International NV |
2014/04/23
|
Authorised |
| Hemangiol |
Human |
propranolol |
propranolol hydrochloride |
EMEA/H/C/002621 |
Pierre Fabre Medicament |
2014/04/23
|
Authorised |
| Parvoduk |
Veterinary |
live attenuated Muscovy duck parvovirus |
live attenuated Muscovy duck parvovirus |
EMEA/V/C/002740 |
Merial |
2014/04/11
|
Lapsed |
| Pregabalin Viatris Pharma (previously Pregabalin Pfizer) |
Human |
pregabalin |
pregabalin |
EMEA/H/C/003880 |
Viatris Healthcare Limited |
2014/04/10
|
Authorised |
| Granupas (previously Para-aminosalicylic acid Lucane) |
Human |
para-aminosalicylic acid |
para-aminosalicylic acid |
EMEA/H/C/002709 |
Eurocept International B. V. |
2014/04/07
|
Withdrawn |
| Rivastigmine 3M Health Care Ltd |
Human |
rivastigmine |
rivastigmine |
EMEA/H/C/003824 |
3M Health Care Limited |
2014/04/03
|
Withdrawn |